Trastuzumab deruxtecan (T-DXd, DS-8201) in HER2-positive metastatic breast cancer previously treated with T-DM1: DESTINY-Breast01 Study

被引:0
作者
Krop, I. [1 ]
Saura Manich, C. [2 ]
Yamashita, T. [3 ]
Park, Y. H. [4 ,5 ]
Kim, S. -B. K. [6 ]
Tamura, K. [7 ]
Andre, F. [8 ]
Iwata, H. [9 ]
Ito, Y. [7 ]
Tsurutani, J. [10 ]
Sohn, J. [11 ]
Denduluri, N. [12 ]
Perrin, C. [13 ]
Aogi, K. [14 ]
Tokunaga, E. [15 ]
Im, S. -A. [16 ]
Lee, K. S. [17 ]
Hurvitz, S. [18 ]
Cortes, J. [19 ]
Lee, C. [20 ]
Chen, S. [21 ]
Zhang, L. [22 ]
Shahidi, J. [23 ]
Yver, A. [23 ]
Modi, S. [24 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Vall Hebron Univ Hosp, Oncol, Barcelona, Spain
[3] Kanagawa Canc Ctr, Dept Breast & Endocrine Surg, Yokohama, Kanagawa, Japan
[4] Ewha Womans Univ, Coll Med, Breast Canc, Seoul, South Korea
[5] Corea Sud, Hong Kong, Peoples R China
[6] Assan Med Ctr, Oncol, Seoul, South Korea
[7] Natl Canc Ctr, Oncol, Tokyo, Japan
[8] Inst Natl Sante & Rech Med, Oncol, Villejuif, France
[9] Aichi Canc Ctr Hosp, Oncol, Nagoya, Aichi, Japan
[10] Kindai Univ Hosp, Osaka, Japan
[11] Yonsei Proteome Res Ctr, Oncol, Seoul, South Korea
[12] Virginia Canc Specialists, Arlington, VA USA
[13] Ctr Eugene Marquis, Oncol, Rennes, France
[14] Shikoku Canc Ctr, Breast Oncol, Matsuyama, Ehime, Japan
[15] Natl Hosp Org Kyushu Canc Ctr, Breast Oncol, Fukuoka, Japan
[16] Seoul Natl Univ, Coll Med, Oncol, Seoul, South Korea
[17] Natl Canc Ctr Korea, Goyang Si, South Korea
[18] Ronald Reagan UCLA Med Ctr, Oncol, Los Angeles, CA USA
[19] Hosp Ruber Int, Breast Canc, Madrid, Spain
[20] Mt Sinai Hosp, New York, NY 10029 USA
[21] Queens Univ, Kingston, ON, Canada
[22] Ohio Columbus, Oncol, Columbus, OH USA
[23] Daiichi Sankyo Schweiz AG, Oncol, Thalwil, Switzerland
[24] Mem Sloan Kettering Canc Ctr, Oncol, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P40
引用
收藏
页码:25S / 25S
页数:1
相关论文
empty
未找到相关数据